Oncology Clinical Trials in Albuquerque, NM
As of August 2026, 87 paid clinical trials are recruiting for Oncology in Albuquerque, New Mexico. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
87 clinical trials for Oncology
·Clear filters·Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]
A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
A Clinical Study of YL205 in Patients With Advanced Solid Tumors
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Clinical Pre-screening Protocol for Ovarian Cancer
A Prospective Registry to Enable Collection of Standardized Routine Care Oncology Patient Data
BostonGene and Exigent Genomic INsight Study
Collection of Sputum and Labeling for Lung Cancer
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Cost Communication and Financial Navigation in Cancer Patients (COSTCOM)
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Top Research Study Locations in Albuquerque
Researchers run research studies in Albuquerque, NM at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| University of New Mexico Cancer Center | Acute Myeloid Leukemia, Malignant Solid Neoplasm, Recurrent Endometrial Carcinoma | 78 |
| University of New Mexico | Infant, Small for Gestational Age, Chronic Pain, Diabetes | 44 |
| Presbyterian Kaseman Hospital | Anatomic Stage II Breast Cancer AJCC v8, Melanoma, Metastatic Breast Cancer | 14 |
| University of New Mexico Comprehensive Cancer Center | Anemia, Cancer, Cancer Risk | 13 |
| University of New Mexico Health Sciences Center | Interstitial Lung Disease, AVM, Arteriovenous Malformations | 13 |
| Presbyterian Hospital | B Acute Lymphoblastic Leukemia, Malignant Solid Neoplasm, Acute Myeloid Leukemia | 12 |
| University of New Mexico Hospital | Hidradenitis Suppurativa (HS), Lumbar Spinal Stenosis, Postoperative Physical Functioning | 7 |
| Lovelace Medical Center-Saint Joseph Square | Malignant Solid Neoplasm, Melanoma, Acute Lymphoblastic Leukemia | 6 |
| Lovelace Women's Hospital | Malignant Solid Neoplasm, Melanoma, Acute Lymphoblastic Leukemia | 6 |
| Albuquerque Clinical Trials, Inc. | Obesity, Overweight, Acute Gout Flare | 5 |
| The Mind Research Network | Aging Disorder, Alcohol Use Disorder, Cannabis Use Disorder | 5 |
| New Mexico VA Health Care System, Albuquerque, NM | Atherosclerosis, Bipolar Disorder, Chronic Kidney Disease (CKD) Stage 5 | 4 |
| Vision Research Center Eye Associates of New Mexico | Age-Related Macular Degeneration, Choroidal Neovascularization, Diabetic Retinopathy, DR | 4 |
| Albuquerque Clinical Trials | Acute Migraine, Migraine, Type 2 Diabetes | 3 |
| New Mexico Heart Institute | Atrial Fibrillation, Cardiovascular Diseases, Heart Diseases | 3 |
| New Mexico Oncology Hematology Consultants | Cancer, Malignant Neoplasm, Metastatic Castration-Resistant Prostate Cancer | 3 |
| The University of New Mexico Comprehensive Cancer Center | Advanced Solid Tumors, Lymphoma, Non-Hodgkin, Metastatic Breast Cancer | 3 |
| University of New Mexico Health Science Center | Chronic Kidney Diseases, Cognitive Change, Depression | 3 |
| New Mexico Oncology Hematology Consultants Ltd. | Metastatic Castration-resistant Prostate Cancer, Triple Negative Breast Neoplasms, Triple-Negative Breast Cancer | 3 |
| 89bio Clinical Study Site | Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis, Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis | 2 |
| Albuquerque Rehabilitation and Rheumatology | Arthritis, Psoriatic | 2 |
| Eye Associates of New Mexico, Vision Research Center | Macular Edema Secondary to Inflammation | 2 |
| IMA Clinical Research | Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a), Major Depressive Disorder | 2 |
| IMA Clinical Research - Albuquerque | Alzheimers Disease | 2 |
| Lovelace Health System | Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation, Pulmonary Embolism | 2 |
Active & Upcoming Studies in Albuquerque (2026)
Recruiting trials in Albuquerque grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (123 active studies)
- A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer. · Phase 2, Phase 3 · Eikon Therapeutics
- Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia · Phase 3 · Children's Oncology Group
Cardiovascular (24 active studies)
- Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease · Phase 3 · Alnylam Pharmaceuticals
- Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention · Phase 4 · Duke University
Diabetes & metabolic (21 active studies)
- A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar · Phase 3 · Boehringer Ingelheim
- A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus · Phase 3 · AstraZeneca
Neurology & pain (18 active studies)
- A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine · Phase 3 · Kallyope Inc.
- A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine · Phase 3 · Kallyope Inc.
Eye & vision (9 active studies)
- A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration · Phase 3 · Amgen
- A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002) · Phase 2, Phase 3 · EyeBiotech Ltd.
Mental health & behavior (8 active studies)
- Enhancing Veteran-Clinical Collaboration in VA PRRCs · VA Office of Research and Development
- Group Psilocybin-Assisted Therapy for Post-Traumatic Stress Disorder · Phase 1 · University of New Mexico
Pediatric (5 active studies)
- Target Trial Emulation for Pharmacologic Treatment of Neonatal Opioid Withdrawal Syndrome · HELP for NOWS Consortium
- Neonatal Platelet Transfusion Threshold Trial · NICHD Neonatal Research Network
Vaccines (3 active studies)
- Magnetic Resonance Analysis of Neural Inflammatory Factors and External Stimulation · Phase 2 · University of New Mexico
- A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose · Phase 3 · Pfizer
Common conditions studied in Albuquerque
- Acute Myeloid Leukemia (8 active studies)
- Breast Cancer (8 active studies)
- Ovarian Cancer (8 active studies)
- Endometrial Cancer (7 active studies)
- Malignant Solid Neoplasm (7 active studies)
- Obesity (6 active studies)
Leading research sponsors in Albuquerque
- National Cancer Institute (NCI)
- University of New Mexico
- NRG Oncology
- AstraZeneca
- Children's Oncology Group
Frequently asked questions
How many paid clinical trials are currently recruiting in Albuquerque?
There are approximately 323 recruiting clinical trials in Albuquerque, New Mexico listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Albuquerque pay participants?
Most recruiting trials in Albuquerque compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Albuquerque?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Albuquerque?
The most common conditions under active study in Albuquerque include Acute Myeloid Leukemia (8), Breast Cancer (8), Ovarian Cancer (8), Endometrial Cancer (7), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Albuquerque?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Albuquerque on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Albuquerque?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Albuquerque?
Recruiting research sites in Albuquerque include University of New Mexico Cancer Center, University of New Mexico, Presbyterian Kaseman Hospital, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Albuquerque right now?
The largest active categories in Albuquerque are Cancer & tumors (123), Cardiovascular (24), Diabetes & metabolic (21). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.